Ellicott City, MD, United States of America

Abdel Hamad

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2000-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Abdel Hamad

Introduction

Abdel Hamad is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of immunology through his innovative patents. With a total of 3 patents, his work focuses on molecular complexes that modify immune responses.

Latest Patents

Hamad's latest patents include groundbreaking compositions that comprise a cell in which a molecular complex with high affinity for its cognate ligand is bound to the surface of the cell. These molecular complexes are formed by covalently linking extracellular domains of transmembrane heterodimeric proteins, particularly T cell receptor and major histocompatibility complex proteins, to the heavy and light chains of immunoglobulin molecules. The applications of these molecular complexes are vast, as they can be used to detect and regulate antigen-specific T cells and serve as therapeutic agents for treating disorders involving immune system regulation, such as allergies, autoimmune diseases, tumors, infections, and transplant rejection.

Another patent focuses on the creation of soluble multivalent molecular complexes with high affinity for their cognate ligands. This innovation also utilizes the extracellular domains of transmembrane heterodimeric proteins linked to immunoglobulin molecules. The potential of these molecular complexes extends to various therapeutic applications, including the regulation of immune responses.

Career Highlights

Abdel Hamad is affiliated with The Johns Hopkins University, where he continues to advance his research and innovations in immunology. His work has garnered attention for its potential to revolutionize treatments for immune-related disorders.

Collaborations

Hamad collaborates with esteemed colleagues such as Jonathan Schneck and Sean O'Herrin, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Abdel Hamad's contributions to the field of immunology through his patents highlight the importance of innovative research in developing new therapeutic strategies. His work exemplifies the potential of molecular complexes in modifying immune responses and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…